• About
  • Services
  • Clients
  • Client Media
    • Client News
    • Client Videos
    • CEO Insights
  • PCG Research
  • PCG Digital
    • PCG Digital Tech Watch
    • PCG Digital Biotech Watch
  • Contact
  • follow:

  • 1 Jun

    Key Binding Characteristics of Dusquetide to Important Intracellular Protein Identified

    Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today a publication describing the binding of… Read More..

    Share this:
  • 25 May

    BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors

    As BIONIK Laboratories (BNKL) marks National Stroke Awareness Month, Interim CEO, Richard Russo, talks about what's next for the company New York, New York--(Newsfile Corp. - May 25, 2022) - PCG Digital - Stroke is an enormous public health issue that can strike anyone at any time, regardless of age… Read More..

    Share this:
  • 9 May

    Recruiter.com to Host First Quarter 2022 Earnings Conference Call

    Call to be held Monday, May 16th at 4:30pm EST NEW YORK, NY / ACCESSWIRE / May 9, 2022 / Recruiter.com Group, Inc. (NASDAQ:RCRT)(NASDAQ:RCRTW) ("Recruiter.com"), a recruiting solutionsplatform, announced today that it will host an earnings conference call to discuss its results of operations for the first quarter of 2022.… Read More..

    Share this:
« Previous 1 2 3 4 5 6 … 39 Next »
  • PCG Advisory GroupFollow

    PCG Advisory Group
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    30 Jun

    Soligenix (NASDAQ:SNGX) Continues on Its Track by Making Progress on Milestones
    https://t.co/aaBZixC993

    Reply on Twitter 1542569911205101568Retweet on Twitter 15425699112051015689Like on Twitter 154256991120510156891Twitter 1542569911205101568
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    28 Jun

    Asensus Surgical: (NYSE American: $ASXC) Key commercial and regulatory milestones expected during the second half of 2022
    #surgicalrobotics #roboticsurgicalsystem #investors #DayTrading #investment #smallcaps
    Read our disclosures at https://t.co/RU1aW7XYbc
    https://t.co/Xxflcrbgiw

    Reply on Twitter 1541839295195058181Retweet on Twitter 1541839295195058181Like on Twitter 15418392951950581811Twitter 1541839295195058181
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    28 Jun

    Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Synthetic Hypericin in the Treatment of Psoriasis https://t.co/xjswtZ8Sk8 #biopharma #stocks #stockstowatch #stockmarket #investors #daytrader #investing #SNGX $SNGX Read our disclosures at https://t.co/RU1aW7XYbc

    Reply on Twitter 1541802097477390338Retweet on Twitter 15418020974773903381Like on Twitter 1541802097477390338Twitter 1541802097477390338
    Load More...
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client Media
      • Client News
      • Client Videos
      • CEO Insights
    • PCG Research
    • PCG Digital
      • PCG Digital Tech Watch
      • PCG Digital Biotech Watch
    • Contact